{
    "ticker": "ALKT",
    "name": "Alkermes plc",
    "description": "Alkermes plc is a global biopharmaceutical company focused on the treatment of central nervous system (CNS) diseases. Founded in 1987 and headquartered in Dublin, Ireland, Alkermes develops innovative medicines for patients with complex conditions such as schizophrenia, depression, and addiction. The company leverages its proprietary drug delivery technologies and a deep understanding of CNS biology to create differentiated therapies that address unmet medical needs. Alkermes is best known for its lead products, including Vivitrol, a medication for the treatment of alcohol dependence and opioid dependence, and Aristada, an injectable formulation for the treatment of schizophrenia. Committed to advancing mental health treatment, Alkermes invests in research and development to expand its pipeline, with a strong focus on novel therapies that enhance patient outcomes. The company's mission is to provide hope and improve the lives of patients by transforming the treatment landscape for CNS disorders through science and innovation.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Dublin, Ireland",
    "founded": "1987",
    "website": "https://www.alkermes.com",
    "ceo": "Richard Pops",
    "social_media": {
        "twitter": "https://twitter.com/alkermes",
        "linkedin": "https://www.linkedin.com/company/alkermes"
    },
    "investor_relations": "https://investors.alkermes.com",
    "key_executives": [
        {
            "name": "Richard Pops",
            "position": "CEO"
        },
        {
            "name": "Jim Frates",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "CNS Treatments",
            "products": [
                "Vivitrol",
                "Aristada"
            ]
        }
    ],
    "seo": {
        "meta_title": "Alkermes plc | Innovative CNS Treatments",
        "meta_description": "Explore Alkermes plc, a biopharmaceutical company dedicated to developing innovative therapies for CNS diseases. Learn about their commitment to improving patient outcomes.",
        "keywords": [
            "Alkermes",
            "Biopharmaceuticals",
            "CNS Treatments",
            "Vivitrol",
            "Aristada",
            "Mental Health"
        ]
    },
    "faq": [
        {
            "question": "What is Alkermes known for?",
            "answer": "Alkermes is known for its innovative treatments for central nervous system diseases, including alcohol and opioid dependence."
        },
        {
            "question": "Who is the CEO of Alkermes?",
            "answer": "Richard Pops is the CEO of Alkermes plc."
        },
        {
            "question": "Where is Alkermes headquartered?",
            "answer": "Alkermes is headquartered in Dublin, Ireland."
        },
        {
            "question": "What are Alkermes' main products?",
            "answer": "Alkermes' main products include Vivitrol and Aristada."
        },
        {
            "question": "When was Alkermes founded?",
            "answer": "Alkermes was founded in 1987."
        }
    ],
    "competitors": [
        "AMGN",
        "BIIB",
        "REGN",
        "VRTX"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "GILD"
    ]
}